BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1624972)

  • 1. Laboratory profile of sickle cell disease: a cross-sectional analysis. The Cooperative Study of Sickle Cell Disease.
    West MS; Wethers D; Smith J; Steinberg M
    J Clin Epidemiol; 1992 Aug; 45(8):893-909. PubMed ID: 1624972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pitted red cell counts in sickle cell disease. Relationship to age, hemoglobin genotype, and splenic size.
    Fatunde OJ; Scott RB
    Am J Pediatr Hematol Oncol; 1986; 8(4):329-33. PubMed ID: 3799933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormality of erythrocyte membrane n-3 long chain polyunsaturated fatty acids in sickle cell haemoglobin C (HbSC) disease is not as remarkable as in sickle cell anaemia (HbSS).
    Ren H; Ghebremeskel K; Okpala I; Ugochukwu CC; Crawford M; Ibegbulam O
    Prostaglandins Leukot Essent Fatty Acids; 2006 Jan; 74(1):1-6. PubMed ID: 16314081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.
    Drawz P; Ayyappan S; Nouraie M; Saraf S; Gordeuk V; Hostetter T; Gladwin MT; Little J
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):207-15. PubMed ID: 26672090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reference values and hematologic changes from birth to 5 years in patients with sickle cell disease. Cooperative Study of Sickle Cell Disease.
    Brown AK; Sleeper LA; Miller ST; Pegelow CH; Gill FM; Waclawiw MA
    Arch Pediatr Adolesc Med; 1994 Aug; 148(8):796-804. PubMed ID: 7519102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pleiotropic effects of α-thalassemia on HbSS and HbSC sickle cell disease: Reduced erythrocyte cation co-transport activity, serum erythropoietin, and transfusion burden, do not translate into increased survival.
    Brewin JN; Nardo-Marino A; Stuart-Smith S; El Hoss S; Hanneman A; Strouboulis J; Menzel S; Gibson JS; Rees DC
    Am J Hematol; 2022 Oct; 97(10):1275-1285. PubMed ID: 35802781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of some coagulation parameters in steady state HBSC disease patients.
    Ajuwon MD; Olayemi E; Benneh AA
    Pan Afr Med J; 2014; 19():289. PubMed ID: 25870744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pattern of sickle cell disease in pregnancy in Lagos, Nigeria.
    Ogedengbe OK; Akinyanju O
    West Afr J Med; 1993; 12(2):96-100. PubMed ID: 8398940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haematological change in sickle cell-haemoglobin C disease and in sickle cell-beta thalassaemia: a cohort study from birth.
    Stevens MC; Maude GH; Beckford M; Grandison Y; Mason K; Serjeant BE; Taylor B; Topley JM; Serjeant GR
    Br J Haematol; 1985 Jun; 60(2):279-92. PubMed ID: 4005180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic Administration of Hydroxyurea (HU) Benefits Caucasian Patients with Sickle-Beta Thalassemia.
    Di Maggio R; Hsieh MM; Zhao X; Calvaruso G; Rigano P; Renda D; Tisdale JF; Maggio A
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of alpha thalassaemia on the rheology of homozygous sickle cell disease.
    Serjeant BE; Mason KP; Kenny MW; Stuart J; Higgs DR; Weatherall DJ; Hayes RJ; Serjeant GR
    Br J Haematol; 1983 Nov; 55(3):479-86. PubMed ID: 6639889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total Serum Magnesium Levels and Calcium-To-Magnesium Ratio in Sickle Cell Disease.
    Antwi-Boasiako C; Kusi-Mensah YA; Hayfron-Benjamin C; Aryee R; Dankwah GB; Kwawukume LA; Darkwa EO
    Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31470666
    [No Abstract]   [Full Text] [Related]  

  • 13. Platelet P-selectin and platelet mass, volume and component in sickle cell disease: relationship to genotype.
    Mohan JS; Lip GY; Bareford D; Blann AD
    Thromb Res; 2006; 117(6):623-9. PubMed ID: 16051315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse clinical and obstetric outcomes among pregnant women with different sickle cell disease genotypes.
    Silva FAC; Ferreira ALCG; Hazin-Costa MF; Dias MLG; Araújo AS; Souza AI
    Int J Gynaecol Obstet; 2018 Oct; 143(1):89-93. PubMed ID: 30030929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endotoxinaemia in sickle cell disease.
    Thomson AP; Dick M
    Clin Lab Haematol; 1988; 10(4):397-401. PubMed ID: 3074892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocytosis is associated with hemolysis in sickle cell disease.
    Wongtong N; Jones S; Deng Y; Cai J; Ataga KI
    Hematology; 2015 Dec; 20(10):593-7. PubMed ID: 25875078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Children with HbSβ
    Day ME; Rodeghier M; DeBaun MR
    Pediatr Blood Cancer; 2018 Nov; 65(11):e27352. PubMed ID: 30094930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of alpha-thalassemia-2 on the developmental changes of hematological values in children with sickle cell disease from Georgia.
    Felice AE; McKie KM; Cleek MP; Marino EM; Kutlar A; McKie VC
    Am J Hematol; 1987 Aug; 25(4):389-400. PubMed ID: 2441597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional and temporal variation in oscillatory blood flow in sickle cell disease.
    Kennedy AP; Williams B; Meydrech EF; Steinberg MH
    Am J Hematol; 1988 Jun; 28(2):92-4. PubMed ID: 2969189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disturbance of plasma and platelet thrombospondin levels in sickle cell disease.
    Browne PV; Mosher DF; Steinberg MH; Hebbel RP
    Am J Hematol; 1996 Apr; 51(4):296-301. PubMed ID: 8602630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.